Table 1: Hydrostatin-AMP2 MIC against Escherichia coli is 16 μg/mL.
- Measure
- MIC
- Value
- 16 µg/mL
- Target
- Escherichia coli
- Assay
- Not reported by source
Primary literature evidence
Search paper-level observations with their value, target, assay, evidence sentence, source location, and stable record links. Evidence without a safely standardized sequence remains visible without being misrepresented as a canonical peptide.
Evidence records
Table 1: Hydrostatin-AMP2 MIC against Escherichia coli is 16 μg/mL.
Table 1: Hydrostatin-AMP2 MBC against Escherichia coli is 32 μg/mL (reported as MIC/MBC 16/32).
Table 1: Hydrostatin-AMP2 MIC against Klebsiella pneumoniae 44 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 48 is 16 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 49 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 50 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 51 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against Propionibacterium acnes is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against Staphylococcus aureus is 32 μg/mL.
Table 2: Control MIC of Hydrostatin-AMP2 against E. coli is 16 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 50 mM NaCl is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 100 mM NaCl is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 150 mM NaCl is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 200 mM NaCl is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 1 mM CaCl2 is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 2 mM CaCl2 is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 4 mM CaCl2 is 128 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 1h in human serum is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 2h in human serum is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 3h in human serum is 32 μg/mL.
Names such as P1, PEP1, or peptide 1 are paper-local labels. Search results group them by publication and never assume cross-paper molecular identity without sequence or explicit structural evidence.